| Prospective genotyping of hepatocellular carcinoma: clinical implications of next-generation sequencing for matching patients to targeted and immune therapies JJ Harding, S Nandakumar, J Armenia, DN Khalil, M Albano, M Ly, J Shia, ... Clinical Cancer Research 25 (7), 2116-2126, 2019 | 468 | 2019 |
| Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma GK Abou-Alfa, S Qin, BY Ryoo, SN Lu, CJ Yen, YH Feng, HY Lim, F Izzo, ... Annals of Oncology 29 (6), 1402-1408, 2018 | 176 | 2018 |
| Frequency, morbidity, and mortality of bone metastases in advanced hepatocellular carcinoma JJ Harding, G Abu-Zeinah, JF Chou, DH Owen, M Ly, MA Lowery, ... Journal of the National Comprehensive Cancer Network 16 (1), 50-58, 2018 | 65 | 2018 |
| Germline alterations in patients with biliary tract cancers: a spectrum of significant and previously underappreciated findings H Maynard, ZK Stadler, MF Berger, DB Solit, M Ly, MA Lowery, ... Cancer 126 (9), 1995-2002, 2020 | 40 | 2020 |
| Phase II multicenter, open‐label study of oral enmd‐2076 for the treatment of patients with advanced fibrolamellar carcinoma GK Abou‐Alfa, R Mayer, AP Venook, AF O'Neill, MS Beg, M LaQuaglia, ... The oncologist 25 (12), e1837-e1845, 2020 | 27 | 2020 |
| Development of an advance care planning paradigm for advanced cancer: person-centered oncologic care and choices (P-COCC) AS Epstein, EM O’Reilly, E Shuk, W Breitbart, MA Shah, M Ly, R Tayler, ... Psycho-oncology 26 (6), 866, 2017 | 23 | 2017 |
| A multicenter randomized three‐arm Phase II study of (1) Everolimus,(2) Estrogen Deprivation Therapy (EDT) with Leuprolide+ Letrozole, and (3) Everolimus+ EDT in patients with … I El Dika, RJ Mayer, AP Venook, M Capanu, MP LaQuaglia, R Kobos, ... The oncologist 25 (11), 925-e1603, 2020 | 22 | 2020 |
| Initial experience with scalp sparing radiation with concurrent temozolomide and tumor treatment fields (SPARE) for patients with newly diagnosed glioblastoma A Song, V Bar-Ad, N Martinez, J Glass, DW Andrews, K Judy, JJ Evans, ... Journal of Neuro-Oncology 147, 653-661, 2020 | 22 | 2020 |
| Scalp-sparing radiation with concurrent temozolomide and tumor treating fields (SPARE) for patients with newly diagnosed glioblastoma R Miller, A Song, A Ali, M Niazi, V Bar-Ad, N Martinez, J Glass, I Alnahhas, ... Frontiers in oncology 12, 896246, 2022 | 21 | 2022 |
| Phase II trial of sorafenib and doxorubicin in patients with advanced hepatocellular carcinoma after disease progression on sorafenib I El Dika, M Capanu, JF Chou, JJ Harding, M Ly, AD Hrabovsky, RKG Do, ... Cancer Medicine 9 (20), 7453-7459, 2020 | 11 | 2020 |
| A phase I trial of binimetinib in combination with gemcitabine (G) and cisplatin (C) patients (pts) with untreated advanced biliary cancer (ABC). MA Lowery, EM O'Reilly, JJ Harding, E Salehi, E Hollywood, M Bradley, ... Journal of Clinical Oncology 33 (15_suppl), e15125-e15125, 2015 | 11 | 2015 |
| ALKYLOXYPHOSPHONIUM SALTS. 5. SELECTIVE NEOPENTYL NUCLEOPHILIC SUBSTITUTIONS WITHOUT REARRANGEMENT STARTING WITH 2, 2-DIMETHYLPROPANE-1, 3-DIOL B Castro, M Ly, C Selve Tetrahedron Letters, 4455-4458, 1973 | 9 | 1973 |
| Randomized phase II study of everolimus (E), leuprolide+ letrozole (LL), and E+ LL (ELL) in patients (pts) with unresectable fibrolamellar carcinoma (FLC). GK Abou-Alfa, RJ Mayer, D Cosgrove, M Capanu, MA Choti, CE Atreya, ... Journal of Clinical Oncology 33 (15_suppl), e15149-e15149, 2015 | 6 | 2015 |
| An open-label, multi-center, phase I/II, dose escalation study of IV TKM-080301 in subjects with advanced hepatocellular carcinoma GK Abou-Alfa, JH Yoon, M Modiano, BY Ryoo, T Yau, B Freilich, J Knox, ... European Journal of Cancer 1 (69), S22, 2016 | 5 | 2016 |
| ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma. G Abou-Alfa, S Qin, B Ryoo, S Lu, C Yen, Y Feng, H Lim, F Izzo, ... | 4 | 2018 |
| Comprehensive molecular profiling and analysis of mutual exclusivity of genetic aberrations (MEGA) of intra-and extrahepatic cholangiocarcinomas (IHC and EHC) evaluation of … MA Lowery, R Ptashkin, E Jordan, MF Berger, A Zehir, NE Kemeny, ... Journal of Clinical Oncology 34 (15_suppl), 4088-4088, 2016 | 3 | 2016 |
| CTNI-21. Scalp sparing radiation with concurrent temozolomide and tumor treatment fields (spare) for patients with newly diagnosed glioblastoma R Miller, A Song, A Ali, V Bar-Ad, N Martinez, J Glass, D Andrews, K Judy, ... Neuro-Oncology 22 (Supplement_2), ii46-ii47, 2020 | 2 | 2020 |
| Sels d'alkyloxyphosphonium. V-Substitutions nucleophiles neopentyliques selectives sans transposition a partir du dimethyl-2, 2 propane diol-1, 3 B Castro, M Ly, C Selve Tetrahedron Letters 14 (45), 4455-4458, 1973 | 2 | 1973 |
| Hepatic arterial infusion (HAI) chemotherapy via the medtronic pump-assessing dose delivery, response rates and toxicity. LC Connell, L Fiedler, S Dickinson, M Ly, K Harrington, WR Jarnagin, ... Journal of Clinical Oncology 38 (15_suppl), e16007-e16007, 2020 | 1 | 2020 |
| ACTR-49. Initial experience with scalp preservation and radiation plus concurrent alternating electric tumor-treating fields (SPARE) for glioblastoma patients A Song, M Ly, V Bar-Ad, M Werner-Wasik, J Glass, N Martinez, D Andrews, ... Neuro-Oncology 21 (Suppl 6), vi24, 2019 | 1 | 2019 |
